Perspective Volume 13 Issue 2
Received: October 21, 2026 | Published: November 5, 2026
Citation: Maheshwari A, Singla S, Patil S, et al. Beyond type 1 and type 2: the case for CGM-based glycemic phenotyping to guide diabetes therapy. J Diabetes Metab Disord Control. 2026;13(2):116-122. DOI: 10.15406/jdmdc.2026.13.00321
©2026 Maheshwari, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.